CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 62.589
AS - Asia 38.141
EU - Europa 29.696
SA - Sud America 4.697
AF - Africa 517
OC - Oceania 161
Continente sconosciuto - Info sul continente non disponibili 64
AN - Antartide 1
Totale 135.866
Nazione #
US - Stati Uniti d'America 61.102
SG - Singapore 12.925
CN - Cina 8.576
VN - Vietnam 7.048
HK - Hong Kong 5.623
IT - Italia 5.500
RU - Federazione Russa 5.079
DE - Germania 4.450
BR - Brasile 3.898
SE - Svezia 3.531
IE - Irlanda 3.179
UA - Ucraina 2.544
GB - Regno Unito 1.540
CA - Canada 1.099
FI - Finlandia 802
IN - India 716
KR - Corea 674
FR - Francia 652
AT - Austria 599
ID - Indonesia 504
JP - Giappone 373
NL - Olanda 365
TR - Turchia 357
AR - Argentina 336
BD - Bangladesh 277
DK - Danimarca 275
MX - Messico 259
ZA - Sudafrica 240
LT - Lituania 235
PL - Polonia 220
ES - Italia 194
IQ - Iraq 163
BE - Belgio 153
EC - Ecuador 143
AU - Australia 131
PK - Pakistan 108
IR - Iran 99
TW - Taiwan 81
SA - Arabia Saudita 71
CO - Colombia 67
EG - Egitto 66
UZ - Uzbekistan 65
MY - Malesia 64
PY - Paraguay 63
VE - Venezuela 61
CH - Svizzera 55
EU - Europa 53
IL - Israele 50
CZ - Repubblica Ceca 48
AE - Emirati Arabi Uniti 46
MA - Marocco 46
KZ - Kazakistan 44
PE - Perù 44
JO - Giordania 41
PT - Portogallo 41
TN - Tunisia 38
UY - Uruguay 36
RO - Romania 35
CL - Cile 33
GR - Grecia 33
KE - Kenya 31
PH - Filippine 29
AZ - Azerbaigian 28
NZ - Nuova Zelanda 25
BG - Bulgaria 22
HR - Croazia 22
NP - Nepal 22
TH - Thailandia 22
DO - Repubblica Dominicana 21
AL - Albania 20
CR - Costa Rica 20
ET - Etiopia 20
KG - Kirghizistan 19
HN - Honduras 18
OM - Oman 18
NO - Norvegia 17
RS - Serbia 17
DZ - Algeria 16
JM - Giamaica 16
BH - Bahrain 15
LB - Libano 15
PA - Panama 14
BO - Bolivia 13
SC - Seychelles 12
HU - Ungheria 11
LV - Lettonia 11
PS - Palestinian Territory 11
MD - Moldavia 10
AO - Angola 9
GT - Guatemala 9
KW - Kuwait 9
TT - Trinidad e Tobago 9
SY - Repubblica araba siriana 8
LU - Lussemburgo 7
NI - Nicaragua 7
SN - Senegal 7
BN - Brunei Darussalam 6
BY - Bielorussia 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
Totale 135.754
Città #
Ann Arbor 9.449
Singapore 7.458
Hong Kong 5.548
Woodbridge 4.641
Ashburn 4.472
Dallas 4.331
Fairfield 3.561
Houston 3.496
Dublin 3.082
Chandler 2.845
Jacksonville 2.537
Frankfurt am Main 2.433
Wilmington 2.288
Ho Chi Minh City 2.183
Milan 1.780
Dearborn 1.763
Hanoi 1.615
New York 1.539
Seattle 1.419
Santa Clara 1.327
Beijing 1.275
Princeton 1.244
Cambridge 1.186
Hefei 966
Los Angeles 839
Nanjing 727
Boardman 602
Shanghai 552
The Dalles 508
Vienna 485
Hangzhou 463
Seoul 460
Lawrence 459
Moscow 458
Altamura 450
Chicago 417
Lachine 413
Buffalo 400
Jakarta 392
Council Bluffs 371
São Paulo 369
Guangzhou 323
Dong Ket 256
Munich 248
Toronto 243
Helsinki 226
Nanchang 220
San Diego 207
Shenyang 207
Andover 206
Rome 206
Vilnius 195
Haiphong 194
Tokyo 194
Da Nang 175
London 164
Ha Long 162
Nuremberg 160
Changsha 159
Hebei 154
Biên Hòa 153
Tianjin 149
Rio de Janeiro 147
Warsaw 138
Falls Church 136
Hải Dương 134
Jinan 128
Brooklyn 127
Phoenix 123
Ottawa 121
Quận Bình Thạnh 121
Jiaxing 119
Fremont 117
Brussels 116
San Jose 114
Grafing 112
Kazan 112
Atlanta 111
Johannesburg 111
Montreal 106
Stockholm 106
Denver 103
Chennai 102
Thái Nguyên 101
Mountain View 100
Ninh Bình 98
Columbus 97
Pune 96
Salt Lake City 93
Boston 92
Zhengzhou 92
Kent 91
Detroit 90
Can Tho 89
Norwalk 89
Orem 88
Mexico City 87
Huizen 85
Vũng Tàu 85
Bắc Ninh 83
Totale 89.064
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.034
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 697
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 610
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 569
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 551
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 524
CIPN and its mechanism of development 519
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 508
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 503
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 467
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 465
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 464
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 456
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 447
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 442
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 423
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 422
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 399
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 398
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 396
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 392
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 391
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 389
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 389
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 387
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 384
Malattie del Sistema Nervoso 380
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 379
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 378
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 374
Age-related changes in the function and structure of the peripheral sensory pathway in mice 372
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 372
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 366
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 366
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 366
A role for hemopexin in oligodendrocyte differentiation and myelin formation 365
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 364
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 361
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 361
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 358
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 358
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 352
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 342
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials 342
Enhanced brain targeting of engineered solid lipid nanoparticles 341
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 336
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 334
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 333
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 332
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 329
The Italian multiple sclerosis register 323
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 320
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 320
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 315
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 314
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 307
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 305
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 304
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 303
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 303
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 303
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 302
Malattie del Sistema Nervoso 300
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 297
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 296
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 295
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 292
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 291
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 289
Role of MAPKs in platinum-induced neuronal apoptosis 288
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 288
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 288
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 286
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 284
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 279
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 276
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 276
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 276
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 276
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 275
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 273
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 272
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 272
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 270
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 269
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 268
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 267
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 267
In vitro anticancer activity and neurotoxicity of novel heavy metal-based anticancer complexes 266
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 265
Are sigma receptor modulators a weapon against multiple sclerosis disease? 265
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 262
Sex dimorphism in an animal model of multiple sclerosis: Focus on pregnenolone synthesis 262
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 262
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 261
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 261
Totale 35.591
Categoria #
all - tutte 462.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 462.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.054 0 0 0 0 0 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202525.492 1.585 2.872 1.748 1.200 2.163 931 1.391 976 2.945 3.306 2.243 4.132
2025/202637.938 9.639 5.703 7.297 5.637 6.147 3.515 0 0 0 0 0 0
Totale 139.937